CVS Group plc, a leading provider of integrated veterinary services in the UK, has announced the exercise of options over 107,903 new Ordinary Shares under the CVS Group 2020 Long Term Incentive Plan. These shares have been admitted via the block listing for the Company's Long Term Incentive Plans. Following the issuance of these new shares, CVS Group now has a total issued share capital of 71,537,662 Ordinary Shares, each carrying one voting right. The Company holds no Ordinary Shares in treasury, resulting in a total number of voting rights of 71,537,662.
This figure can be used by shareholders to determine if they are required to notify any changes in their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.
CVS Group operates in the UK, Australia, the Netherlands, and the Republic of Ireland, providing veterinary services. The company has approximately 500 veterinary practices, including specialist referral hospitals and out-of-hours sites. In addition to veterinary practices, CVS Group also operates Laboratories, Crematoria, Buying Groups, and an online retail business called "Animed Direct." The company's focus is on providing high-quality clinical services to clients and their animals, with dedicated clinical teams and support colleagues at the core of its strategy.
CVS Group plc is listed on the AIM market. The company's CEO is Richard Fairman, and Scott Morrison serves as the Company Secretary. Peel Hunt LLP and Berenberg are the company's Nominated Adviser & Broker and Joint Broker, respectively. Camarco handles the company's financial PR.